The effect of ulinastatin on acute kidney injury in patients undergoing off-pump cardiac bypass surgery

Table 4 Post-operative outcome in patients with and without ulinastatin

Postoperative outcome	Control group (n = 200)	Ulinastatin group (n = 100)	P value
Acute kidney injury	5 (2.5%)	2 (2.0%)	> 0.999
Creatine level(mg/dL)
Cr0	0.734 ± 0.176	0.734 ± 0.172	0.985
Cr1	0.823 ± 0.216	0.774 ± 0.179	0.040*
Cr2	0.766 ± 0.239	0.748 ± 0.186	0.453
Cr3	0.779 ± 0.304	0.753 ± 0.198	0.374
Cr7	0.832 ± 0.292	0.821 ± 0.193	0.687
Lung complication (%)	30 (15.0%)	12 (12.0%)	0.596
Postop arrhythmia (%)	16 (8.0%)	7 (7.0%)	0.788
Wound complications (%)	19 (9.5%)	8 (8.0%)	0.621
Length of hospital day(day)	15.8 ± 8.5	14.6 ± 7.1	0.222
Length of ICU stay(day)	5.22 ± 7.45	2.91 ± 2.81	< 0.001*

Data are presented as n (%) or mean ± standard deviation
P value* < 0.05 indicates statistical significance
Cr0 Immediate post operation, Cr1 post-operative day 1, Cr2 post-operative day 2, Cr3 post-operative day 3, Cr7 post-operative day 7, ICU Intensive care unit

ISSN: 1749-8090